Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-25-000006

Chief Financial Officer returned 1,150 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Carter Robert Ross Chief Financial Officer 2025-03-19 Returned to the company −1,150 $0.89 $1,022 30,351 D: show line 1 in the form
Loading xslF345X05/wk-form4_1742507796.xml…